Wednesday, October 28th at 11:00 AM CT
Join us for an exclusive presentation with the CEO of CardioWise.
CardioWise developed SQuEEZ™, an FDA-cleared software that evaluates heart muscle health directly from standard cardiac CT scans without new hardware. The technology targets cardiovascular disease, a crisis costing the U.S. healthcare system roughly $223 billion annually.
While traditional scans only check for artery blockages, SQuEEZ measures regional myocardial strain and heart wall contraction. Scans automatically upload to the cloud to analyze heart motion against a database of healthy hearts. Within about a minute, clinicians receive a concise two-page quantitative report via PACS or email.